Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-074344
Filing Date
2010-08-06
Accepted
2010-08-06 16:28:25
Documents
10
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a56328e10vq.htm 10-Q 487081
2 EX-31.1 a56328exv31w1.htm EX-31.1 6742
3 EX-31.2 a56328exv31w2.htm EX-31.2 6769
4 EX-32.1 a56328exv32w1.htm EX-32.1 3917
5 EX-32.2 a56328exv32w2.htm EX-32.2 3953
  Complete submission text file 0000950123-10-074344.txt   2444871

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT wpi-20100630.xml EX-101.INS 342148
7 EX-101 SCHEMA DOCUMENT wpi-20100630.xsd EX-101.SCH 12046
8 EX-101 CALCULATION LINKBASE DOCUMENT wpi-20100630_cal.xml EX-101.CAL 42872
9 EX-101 LABELS LINKBASE DOCUMENT wpi-20100630_lab.xml EX-101.LAB 129868
10 EX-101 PRESENTATION LINKBASE DOCUMENT wpi-20100630_pre.xml EX-101.PRE 74510
Mailing Address 311 BONNIE CIRCLE CORONA CA 92880
Business Address 311 BONNIE CIRCLE CORONA CA 92880 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13305 | Film No.: 10998749
SIC: 2834 Pharmaceutical Preparations